Average Co-Inventor Count = 6.01
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Agouron Pharmaceuticals, Inc. (12 from 174 patents)
2. Syntex (u.s.a.) Inc. (3 from 932 patents)
3. Other (1 from 832,680 patents)
13 patents:
1. 7179918 - HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
2. 6953858 - HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
3. 6849732 - Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
4. 6774243 - Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
5. 6500948 - Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
6. 6376506 - Sulfamide-metalloprotease inhibitors
7. 6355807 - Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates
8. 6153757 - Metalloproteinase inhibitors and intermediates useful for their
9. 6143744 - Sulfamide-metalloprotease inhibitors
10. 6130220 - Sulfamide-metalloprotease inhibitors
11. 5998412 - Sulfamide-metalloprotease inhibitors
12. 5863950 - HIV protease inhibitors
13. 5753653 - Metalloproteinase inhibitors, pharmaceutical compositions containing